The COVID-19 crisis is forcing individuals and companies to adapt fast to new challenges. In this context, several companies are promoting solidarity initiatives and projects to overcome this crisis in the best possible conditions.

| Read more |

(Español) La compañía barcelonesa especializada en firma electrónica, factura electrónica e identidad digital ha cerrado esta nueva ronda de financiación que consolida su plan de crecimiento y expansión en el mercado internacional. La inversión de 2M€ permitirá también su consolidación en el emergente mercado de las identidades digitales basadas en blockchain (SSI).

| Read more |

• The financing ends with a loan capitalisation of €17 million, which brings the total of the operation to 72.2 million.
• It will speed up research into SNF472, a drug designed to treat a rare disease known as calciphylaxis.
• Two new investors are joining the company: Columbus Venture Partners and Alta Life Sciences.

| Read more |

With this round the company will complete the development of its virtual reality solutions for the treatment of anxiety disorders (phobias, panic, post-traumatic stress disorder, obsessive-compulsive disorder), stress management, depression, attention problems such as ADHD, and autism or psychotic spectrum disorders, among many others. To this end, the company is focusing its activities on consolidating clinical activity through international studies that analyze the therapeutic effect of virtual reality in the field of cognitive-behavioral therapy.

| Read more |